Gene therapy demonstrated clinically meaningful vision improvement in legally blind individuals. The therapy is capable of restoring vision even in advanced disease stages. The Latest A recent two-year phase 2b, randomized, double-masked, sham-controlled multicenter clinical trial by Boyer et al. and Nanoscope Therapeutics investigated mutation-agnostic gene therapy for the treatment of permanent and severe
Related Keywords
United States , Texas , , Minute Medicine Inc , Company History , Nanoscope Therapeutics , Nanoscopevisual Acquty , Ophthamology , Retinitis Pigmentosa , Vision Loss , Ophthalmology ,
comparemela.com © 2020. All Rights Reserved.